Balyasny Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-401,394
Closed -$12.2M 2743
2025
Q1
$12.2M Sell
401,394
-685,418
-63% -$26.1M 0.02% 807
2024
Q4
$43.1M Buy
+1,086,812
New +$49M 0.06% 367
2023
Q4
Sell
-315,560
Closed -$22.2M 2433
2023
Q3
$22.2M Buy
+315,560
New +$23.6M 0.05% 539
2023
Q1
Sell
-4,182
Closed -$344K 2579
2022
Q4
$344K Sell
4,182
-18,157
-81% -$1.5M ﹤0.01% 1951
2022
Q3
$1.75M Buy
+22,339
New +$1.79M 0.01% 1557
2021
Q2
Sell
-8,330
Closed -$476K 1914
2021
Q1
$476K Buy
+8,330
New +$451K ﹤0.01% 1414
2020
Q2
Sell
-42,513
Closed -$780K 1084
2020
Q1
$780K Sell
42,513
-19,816
-32% -$567K 0.01% 816
2019
Q4
$2.07M Buy
+62,329
New +$1.95M 0.01% 751
2018
Q1
Sell
-241,248
Closed -$7.87M 1892
2017
Q4
$7.87M Buy
+241,248
New +$8.36M 0.02% 714
2017
Q2
Sell
-78,023
Closed -$3.4M 1437
2017
Q1
$3.4M Buy
+78,023
New +$3.17M 0.02% 790
2016
Q1
Sell
-135,248
Closed -$8.45M 1241
2015
Q4
$8.45M Buy
+135,248
New +$8.81M 0.06% 396
2013
Q3
Sell
-21,761
Closed -$720K 557
2013
Q2
$720K Buy
+21,761
New +$706K 0.01% 509

Other funds holding ACHC

Balyasny Asset Management's ACHC Position: Q2 2025 in Review

Balyasny Asset Management sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 401,394 shares — an estimated $12.2M sold.

Balyasny Asset Management first reported a position in ACHC in Q2 2013 and held it in 12 quarters. The position peaked at $43.1M in Q4 2024. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

  • Balyasny Asset Management reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 401,394 Acadia Healthcare shares in Q2 2025, an estimated $12.2M.
  • Balyasny Asset Management first reported a position in Acadia Healthcare in Q2 2013 and held it in 12 quarters.
  • Balyasny Asset Management's Acadia Healthcare position peaked at $43.1M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.